Cargando…

hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression

In non-small cell lung cancer cell lines, activation of β-catenin independent signaling, via Wnt7a/Frizzled9 signaling, leads to reversal of cellular transformation, reduced anchorage-independent growth and induction of epithelial differentiation. miRNA expression profiling on a human lung adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avasarala, Sreedevi, Van Scoyk, Michelle, Wang, Jianbin, Sechler, Marybeth, Vandervest, Katherine, Brzezinski, Christine, Weekes, Colin, Edwards, Michael G., Arcaroli, John, Davis, Richard E., Bikkavilli, Rama Kamesh, Winn, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711035/ https://www.ncbi.nlm.nih.gov/pubmed/23862015 http://dx.doi.org/10.1242/bio.20134507

Ejemplares similares

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies
por: Sechler, Marybeth, et al.
Publicado: (2013)

Heterotrimeric G-Protein, G(α16), Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer
por: Avasarala, Sreedevi, et al.
Publicado: (2013)

Dishevelled3 is a novel arginine methyl transferase substrate
por: Bikkavilli, Rama Kamesh, et al.
Publicado: (2012)

Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)
por: Sechler, Marybeth, et al.
Publicado: (2015)

PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
por: Avasarala, Sreedevi, et al.
Publicado: (2015)

K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer
por: Bikkavilli, Rama Kamesh, et al.
Publicado: (2017)

Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer
por: Bikkavilli, R K, et al.
Publicado: (2015)

Erratum: Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer
por: Bikkavilli, R K, et al.
Publicado: (2015)

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
por: Sechler, Marybeth, et al.
Publicado: (2017)

Arginine methylation of G3BP1 in response to Wnt3a regulates β-catenin mRNA
por: Bikkavilli, Rama Kamesh, et al.
Publicado: (2011)

Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2
por: Bikkavilli, Rama Kamesh, et al.
Publicado: (2012)

Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
por: Arcaroli, J J, et al.
Publicado: (2013)

Targeting MDM4 Splicing in Cancers
por: Bardot, Boris, et al.
Publicado: (2017)

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain
por: Ilic, Viktoria K., et al.
Publicado: (2022)

Downstream Targets of Cyclic Nucleotides in Plants
por: Świeżawska, Brygida, et al.
Publicado: (2018)

Clinical Overview of MDM2/X-Targeted Therapies
por: Burgess, Andrew, et al.
Publicado: (2016)

Methylation of Wnt7a Is Modulated by DNMT1 and Cigarette Smoke Condensate in Non-Small Cell Lung Cancer
por: Tennis, Meredith A., et al.
Publicado: (2012)

Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
por: Sun, Chengcao, et al.
Publicado: (2016)

Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases
por: Gai, Lili, et al.
Publicado: (2021)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

Serum and Serum Exosomal CircRNAs hsa_circ_0001492, hsa_circ_0001439, and hsa_circ_0000896 as Diagnostic Biomarkers for Lung Adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022)

Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway
por: Xu, Jianhao, et al.
Publicado: (2021)

Targets downstream of Cdk8 in Dictyostelium development
por: Greene, David M, et al.
Publicado: (2011)

Targeting the p53–MDM2 interaction to treat cancer
por: Klein, C, et al.
Publicado: (2004)

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
por: Yuan, Yuan, et al.
Publicado: (2011)

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
por: Miles, Xanthene, et al.
Publicado: (2021)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

Identification of downstream targets and signaling pathways of long non-coding RNA NR_002794 in human trophoblast cells
por: Ma, Yinyao, et al.
Publicado: (2021)

Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1
por: Yang, Jing, et al.
Publicado: (2021)

Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids
por: Chee, Sharon Min Qi, et al.
Publicado: (2017)

A non-canonical plant microRNA target site
por: Brousse, Cécile, et al.
Publicado: (2014)

The core spliceosome as target and effector of non-canonical ATM signaling
por: Tresini, Maria, et al.
Publicado: (2015)

Non-canonical targets destabilize microRNAs in human Argonautes
por: Park, June Hyun, et al.
Publicado: (2017)

Thinking outside the box: non-canonical targets in multiple sclerosis
por: Bierhansl, Laura, et al.
Publicado: (2022)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
por: Zhu, Haohao, et al.
Publicado: (2022)

Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer
por: Yu, Wanjun, et al.
Publicado: (2018)

xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data
por: Uppal, Karan, et al.
Publicado: (2013)

Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013)

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
por: Laroche-Clary, Audrey, et al.
Publicado: (2017)

Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
por: Søgaard, Caroline K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tlgnsgnmqbhkaa2637gb2lve6v